Fotosearch_k18326703_spegelvänd.jpg

SWIPP

About us

Board and Management

OWNERS

So far

Christer Sjögren   is Doctor in Veterinary Medicine (DVM), PhD, and Associate Professor in Pharmacology at the Swedish Royal Veterinary College in 1975, as well as former Consulting Professor in experimental Obstetrics and Gynecology at Uppsala University in Sweden.  He has more than 45 years of experience from leading positions at big pharmaceutical companies such as Pharmacia and Novo Nordisk as well as smaller such as Perstorp Pharma, LIDDS AB, Peptonic Medical AB and others.
Christer Sjögren   is Doctor in Veterinary Medicine (DVM), PhD, and Associate Professor in Pharmacology at the Swedish Royal Veterinary College in 1975, as well as former Consulting Professor in experimental Obstetrics and Gynecology at Uppsala University in Sweden.  He has more than 45 years of experience from leading positions at big pharmaceutical companies such as Pharmacia and Novo Nordisk as well as smaller such as Perstorp Pharma, LIDDS AB, Peptonic Medical AB and others.

Christer Sjögren
is Doctor in Veterinary Medicine (DVM), PhD, and Associate Professor in Pharmacology at the Swedish Royal Veterinary College in 1975, as well as former Consulting Professor in experimental Obstetrics and Gynecology at Uppsala University in Sweden.

He has more than 45 years of experience from leading positions at big pharmaceutical companies such as Pharmacia and Novo Nordisk as well as smaller such as Perstorp Pharma, LIDDS AB, Peptonic Medical AB and others.

Bengt Westrin  has over 26 years industry experience,  spanning from startups to big pharma, from product  development & regulatory affairs to project management  & business development.  Prior to SWIPP he has been CEO of CombiGene AB (publ),  AcuCort AB (publ), Idogen AB (publ), Lipopeptide AB (Stockholm),  and VP Business Development of Camurus AB(publ).  He has also had numerous consultancy assignment for other public  or private companies.  He received his M.Sc. and his Ph.D. at the Faculty of Engineering at Lund University, where he is also Associate Professor since 1999.
Bengt Westrin   has over 26 years industry experience,  spanning from startups to big pharma, from product  development & regulatory affairs to project management  & business development.  Prior to SWIPP he has been CEO of CombiGene AB (publ),  AcuCort AB (publ), Idogen AB (publ), Lipopeptide AB (Stockholm),  and VP Business Development of Camurus AB(publ).  He has also had numerous consultancy assignment for other public  or private companies.  He received his M.Sc. and his Ph.D. at the Faculty of Engineering at Lund University, where he is also Associate Professor since 1999.

Bengt Westrin
has over 26 years industry experience,
spanning from startups to big pharma, from product
development & regulatory affairs to project management
& business development.

Prior to SWIPP he has been CEO of CombiGene AB (publ),
AcuCort AB (publ), Idogen AB (publ), Lipopeptide AB (Stockholm),
and VP Business Development of Camurus AB(publ).

He has also had numerous consultancy assignment for other public
or private companies.

He received his M.Sc. and his Ph.D. at the Faculty of Engineering at Lund University, where he is also Associate Professor since 1999.

Johan Säfholm, M.Sc. Board member
Johan Säfholm   got his Masters degree in Applied Physics from Linköping University in 2003.  He has since gained international experience from development and manufacturing of consumer electronics in different roles such as team leader and product manager.  Johan has worked at Sony Ericsson, ST-Ericsson, Axis and Flatfrog, companies spanning from 40 to 5000 employees with worldwide presence.

Johan Säfholm
got his Masters degree in Applied Physics from Linköping University in 2003.

He has since gained international experience from development and manufacturing of consumer electronics in different roles such as team leader and product manager.

Johan has worked at Sony Ericsson, ST-Ericsson, Axis and Flatfrog, companies spanning from 40 to 5000 employees with worldwide presence.

SWIPP is currently owned by the two co-founders Christer Sjögren and Bengt Westrin, together with three Swedish seed investors and a European investor.

Oct 2017:  
Company founded
Dec 2017:  
First seed funding
Jan 2018:  
National phase entry for first patent application 
Apr 2018:  
Regulatory advice received from the Swedish MPA and UK’s MHRA 
Jul 2018:
Letter-of-intent signed with EU GMP manufacturer
Sept 2018:
Collaboration initiated with EU clinical CRO
Oct 2018:
Submission for Scientific Advice Meeting with Swedish MPA
Oct 2018:
Series A funding